Use access key #2 to skip to page content.
$13.36 -0.51 (-3.68%)
10/10/2008 4:02 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

View All Commentary (SGP)

Recs

1

Avatar Alwayspersevere (55.96) Submitted: 10/24/06 4:55 PM : Outperform Start Price: $22.74 SGP Score: -5.48

Cie has just come out of disarray caused by former management incompetency. Vytorin venture with Merck = big opportunity blossoming. Last weeks earning release showed encouraging improvement( 30% qtr/over same quarter last year). Earning growth should keep on improving at comparable pace in the next 3-4 years. Dividend may be pushed up. Optionnable stock( buy stock sell call).
Stock could reach 35$ january 08. Worth tuning in.

Report this Post Replies: 0 | Reply

Featured Broker Partners